BIOPHARM FORWARD ApS: Financial statements 2014
CVR: 32438784
Source: annual report 2014, Danish Business Authority
26/08/2013 – 25/08/2014
BIOPHARM FORWARD ApS (CVR 32438784) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -2,222 and a net result of DKK -2,214 compared with DKK -1,974 the year before. Equity in the 2014 report amounted to DKK -23,555.
- Gross Profit
- DKK -2,222
- Profit/Loss
- DKK -2,214
- Equity
- DKK -23,555
- Total Assets
- DKK 2,740
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -2 t. | -2 t. | -24 t. | - |
| 2013 | - | -2 t. | -2 t. | -21 t. | - |
| 2012 | - | -11 t. | -47 t. | -19 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of December 14, 2014, Jonas Hink is registered as an owner of BIOPHARM FORWARD ApS with an ownership share of 100%.
BIOPHARM FORWARD ApS has published its annual report for 2013. Gross profit came to DKK -2,016, and the net result was DKK -1,974.
About BIOPHARM FORWARD ApS
BIOPHARM FORWARD ApS is a Danish company of the type Anpartsselskab based in Espergærde, founded in 2009. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jonas Hink. The company is owned by Jonas Hink. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK 997,234 and a net result of DKK 243,660 compared with DKK 385,061 the year before. Equity in the 2025 report amounted to DKK 1,741,315.